2.4.1.9 Html 184 244 1 false 70 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.immunedesign.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - Balance Sheets Sheet http://www.immunedesign.com/role/BalanceSheets Balance Sheets false false R3.htm 1001501 - Statement - Balance Sheets (Parenthetical) Sheet http://www.immunedesign.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 1002000 - Statement - Statements of Operations Sheet http://www.immunedesign.com/role/StatementsOfOperations Statements of Operations false false R5.htm 1003000 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Sheet http://www.immunedesign.com/role/StatementsOfConvertiblePreferredStockAndStockholdersDeficitEquity Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity false false R6.htm 1003001 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Parenthetical Sheet http://www.immunedesign.com/role/StatementsOfConvertiblePreferredStockAndStockholdersDeficitEquityParenthetical Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Parenthetical false false R7.htm 1004000 - Statement - Statements of Cash Flows Sheet http://www.immunedesign.com/role/StatementsOfCashFlows Statements of Cash Flows false false R8.htm 2101100 - Disclosure - Description of the Business Sheet http://www.immunedesign.com/role/DescriptionOfBusiness Description of the Business false false R9.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R10.htm 2103100 - Disclosure - Net Loss Per Share (Notes) Notes http://www.immunedesign.com/role/NetLossPerShareNotes Net Loss Per Share (Notes) false false R11.htm 2104100 - Disclosure - Fair Value of Financial Instruments Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments false false R12.htm 2105100 - Disclosure - Inventory Sheet http://www.immunedesign.com/role/Inventory Inventory false false R13.htm 2106100 - Disclosure - Property and Equipment Sheet http://www.immunedesign.com/role/PropertyAndEquipment Property and Equipment false false R14.htm 2107100 - Disclosure - Accrued Liabilities Sheet http://www.immunedesign.com/role/AccruedLiabilities Accrued Liabilities false false R15.htm 2108100 - Disclosure - Series C Convertible Preferred Stock Warrant Liability Sheet http://www.immunedesign.com/role/SeriesCConvertiblePreferredStockWarrantLiability Series C Convertible Preferred Stock Warrant Liability false false R16.htm 2109100 - Disclosure - Commitments and Contingencies Sheet http://www.immunedesign.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R17.htm 2110100 - Disclosure - License and Collaboration Agreements Sheet http://www.immunedesign.com/role/LicenseAndCollaborationAgreements License and Collaboration Agreements false false R18.htm 2111100 - Disclosure - Convertible Preferred Stock (Notes) Notes http://www.immunedesign.com/role/ConvertiblePreferredStockNotes Convertible Preferred Stock (Notes) false false R19.htm 2112100 - Disclosure - Stockholders' Equity (Deficit) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficit Stockholders' Equity (Deficit) false false R20.htm 2113100 - Disclosure - Income Taxes Sheet http://www.immunedesign.com/role/IncomeTaxes Income Taxes false false R21.htm 2114100 - Disclosure - Legal Proceedings Sheet http://www.immunedesign.com/role/LegalProceedings Legal Proceedings false false R22.htm 2115100 - Disclosure - Employee Benefit Plan Sheet http://www.immunedesign.com/role/EmployeeBenefitPlan Employee Benefit Plan false false R23.htm 2117100 - Disclosure - Selected Quarterly Financial Information (Unaudited) (Notes) Notes http://www.immunedesign.com/role/SelectedQuarterlyFinancialInformationUnauditedNotes Selected Quarterly Financial Information (Unaudited) (Notes) false false R24.htm 2118100 - Disclosure - Subsequent Events Sheet http://www.immunedesign.com/role/SubsequentEvents Subsequent Events false false R25.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R26.htm 2303301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.immunedesign.com/role/NetLossPerShareTables Net Loss Per Share (Tables) false false R27.htm 2304301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) false false R28.htm 2305301 - Disclosure - Inventory (Tables) Sheet http://www.immunedesign.com/role/InventoryTables Inventory (Tables) false false R29.htm 2306301 - Disclosure - Property and Equipment (Tables) Sheet http://www.immunedesign.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) false false R30.htm 2307301 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.immunedesign.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) false false R31.htm 2309301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.immunedesign.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R32.htm 2311301 - Disclosure - Convertible Preferred Stock (Tables) Sheet http://www.immunedesign.com/role/ConvertiblePreferredStockTables Convertible Preferred Stock (Tables) false false R33.htm 2312301 - Disclosure - Stockholders' Equity (Deficit) (Tables) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitTables Stockholders' Equity (Deficit) (Tables) false false R34.htm 2313301 - Disclosure - Income Taxes (Tables) Sheet http://www.immunedesign.com/role/IncomeTaxesTables Income Taxes (Tables) false false R35.htm 2317301 - Disclosure - Selected Quarterly Financial Information (Unaudited) (Tables) Sheet http://www.immunedesign.com/role/SelectedQuarterlyFinancialInformationUnauditedTables Selected Quarterly Financial Information (Unaudited) (Tables) false false R36.htm 2401401 - Disclosure - Description of the Business - Narrative (Details) Sheet http://www.immunedesign.com/role/DescriptionOfBusinessNarrativeDetails Description of the Business - Narrative (Details) false false R37.htm 2401402 - Disclosure - Description of the Business - Initial Public Offering (Details) Sheet http://www.immunedesign.com/role/DescriptionOfBusinessInitialPublicOfferingDetails Description of the Business - Initial Public Offering (Details) false false R38.htm 2402402 - Disclosure - Summary of Significant Accounting Policies - Segments (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesSegmentsDetails Summary of Significant Accounting Policies - Segments (Details) false false R39.htm 2402403 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Inventory (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesInventoryDetails Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Inventory (Details) false false R40.htm 2402404 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Property and Equipment (Details) false false R41.htm 2402405 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Revenue Recognition (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Revenue Recognition (Details) false false R42.htm 2403402 - Disclosure - Net Loss Per Share (Details) Sheet http://www.immunedesign.com/role/NetLossPerShareDetails Net Loss Per Share (Details) false false R43.htm 2404402 - Disclosure - Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) false false R44.htm 2404403 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsNarrativeDetails Fair Value of Financial Instruments - Narrative (Details) false false R45.htm 2404404 - Disclosure - Fair Value of Financial Instruments - Reconciliation of Convertible Preferred Stock Warranty Liability Measured and Recorded at Fair Value on a Recurring Basis (Details) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsReconciliationOfConvertiblePreferredStockWarrantyLiabilityMeasuredAndRecordedAtFairValueOnRecurringBasisDetails Fair Value of Financial Instruments - Reconciliation of Convertible Preferred Stock Warranty Liability Measured and Recorded at Fair Value on a Recurring Basis (Details) false false R46.htm 2405402 - Disclosure - Inventory (Details) Sheet http://www.immunedesign.com/role/InventoryDetails Inventory (Details) false false R47.htm 2406402 - Disclosure - Property and Equipment (Details) Sheet http://www.immunedesign.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) false false R48.htm 2407402 - Disclosure - Accrued Liabilities (Details) Sheet http://www.immunedesign.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) false false R49.htm 2408401 - Disclosure - Series C Convertible Preferred Stock Warrant Liability (Details) Sheet http://www.immunedesign.com/role/SeriesCConvertiblePreferredStockWarrantLiabilityDetails Series C Convertible Preferred Stock Warrant Liability (Details) false false R50.htm 2409402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.immunedesign.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) false false R51.htm 2409403 - Disclosure - Commitments and Contingencies Commitments and Contingencies - Future Minimum Lease Payments (Details) Sheet http://www.immunedesign.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails Commitments and Contingencies Commitments and Contingencies - Future Minimum Lease Payments (Details) false false R52.htm 2410401 - Disclosure - License and Collaboration Agreements - Narrative (Details) Sheet http://www.immunedesign.com/role/LicenseAndCollaborationAgreementsNarrativeDetails License and Collaboration Agreements - Narrative (Details) false false R53.htm 2411402 - Disclosure - Convertible Preferred Stock (Details) Sheet http://www.immunedesign.com/role/ConvertiblePreferredStockDetails Convertible Preferred Stock (Details) false false R54.htm 2411403 - Disclosure - Convertible Preferred Stock Summary of Preferred Shares (Details) Sheet http://www.immunedesign.com/role/ConvertiblePreferredStockSummaryOfPreferredSharesDetails Convertible Preferred Stock Summary of Preferred Shares (Details) false false R55.htm 2412402 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Shares of Common Stock Reserved for Future Issuance (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitScheduleOfSharesOfCommonStockReservedForFutureIssuanceDetails Stockholders' Equity (Deficit) - Schedule of Shares of Common Stock Reserved for Future Issuance (Details) false false R56.htm 2412403 - Disclosure - Stockholders' Equity (Deficit) - Summary of Stock Options (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitSummaryOfStockOptionsDetails Stockholders' Equity (Deficit) - Summary of Stock Options (Details) false false R57.htm 2412404 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Stock-Based Compensation Expense Recognized (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitScheduleOfStockBasedCompensationExpenseRecognizedDetails Stockholders' Equity (Deficit) - Schedule of Stock-Based Compensation Expense Recognized (Details) false false R58.htm 2412405 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Fair Value of Stock Options Granted to Employees (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitScheduleOfFairValueOfStockOptionsGrantedToEmployeesDetails Stockholders' Equity (Deficit) - Schedule of Fair Value of Stock Options Granted to Employees (Details) false false R59.htm 2412406 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityDeficitNarrativeDetails Stockholders' Equity (Deficit) - Narrative (Details) false false R60.htm 2413402 - Disclosure - Income Taxes Effective Income Tax Rate Reconciliation (Details) Sheet http://www.immunedesign.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails Income Taxes Effective Income Tax Rate Reconciliation (Details) false false R61.htm 2413403 - Disclosure - Income Taxes Deferred Tax Asset (Details) Sheet http://www.immunedesign.com/role/IncomeTaxesDeferredTaxAssetDetails Income Taxes Deferred Tax Asset (Details) false false R62.htm 2413404 - Disclosure - Income Taxes (Details) Sheet http://www.immunedesign.com/role/IncomeTaxesDetails Income Taxes (Details) false false R63.htm 2414401 - Disclosure - Legal Proceedings (Details) Sheet http://www.immunedesign.com/role/LegalProceedingsDetails Legal Proceedings (Details) false false R64.htm 2415401 - Disclosure - Employee Benefit Plan - Narrative (Details) Sheet http://www.immunedesign.com/role/EmployeeBenefitPlanNarrativeDetails Employee Benefit Plan - Narrative (Details) false false R65.htm 2417402 - Disclosure - Selected Quarterly Financial Information (Unaudited) (Details) Sheet http://www.immunedesign.com/role/SelectedQuarterlyFinancialInformationUnauditedDetails Selected Quarterly Financial Information (Unaudited) (Details) false false All Reports Book All Reports Element us-gaap_ProceedsFromWarrantExercises had a mix of decimals attribute values: -5 -3. Element us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '2401402 - Disclosure - Description of the Business - Initial Public Offering (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2409402 - Disclosure - Commitments and Contingencies - Narrative (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2410401 - Disclosure - License and Collaboration Agreements - Narrative (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2412406 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 1001501 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Jul. 31, 2014' Process Flow-Through: 1002000 - Statement - Statements of Operations Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 1003001 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Parenthetical Process Flow-Through: Removing column 'Nov. 30, 2012' Process Flow-Through: Removing column 'Oct. 31, 2013' Process Flow-Through: 1004000 - Statement - Statements of Cash Flows imdz-20141231.xml imdz-20141231.xsd imdz-20141231_cal.xml imdz-20141231_def.xml imdz-20141231_lab.xml imdz-20141231_pre.xml true true